Bionano Genomics, Inc. (BNGO)
1.48
-0.09
(-5.73%)
USD |
NASDAQ |
Oct 02, 16:00
1.49
+0.01
(+0.68%)
Pre-Market: 20:00
Bionano Genomics Net Income (Quarterly) : -7.423M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.423M |
| March 31, 2026 | -8.303M |
| December 31, 2025 | -7.933M |
| September 30, 2025 | -8.503M |
| June 30, 2025 | -6.857M |
| March 31, 2025 | -3.102M |
| December 31, 2024 | -20.12M |
| September 30, 2024 | -44.25M |
| June 30, 2024 | -16.22M |
| March 31, 2024 | -31.42M |
| December 31, 2023 | -43.89M |
| September 30, 2023 | -112.57M |
| June 30, 2023 | -38.91M |
| March 31, 2023 | -37.12M |
| December 31, 2022 | -38.68M |
| September 30, 2022 | -31.81M |
| June 30, 2022 | -32.16M |
| March 31, 2022 | -29.95M |
| December 31, 2021 | -22.95M |
| Date | Value |
|---|---|
| September 30, 2021 | -20.75M |
| June 30, 2021 | -18.79M |
| March 31, 2021 | -9.947M |
| December 31, 2020 | -11.73M |
| September 30, 2020 | -10.79M |
| June 30, 2020 | -8.074M |
| March 31, 2020 | -10.51M |
| December 31, 2019 | -7.901M |
| September 30, 2019 | -6.398M |
| June 30, 2019 | -7.665M |
| March 31, 2019 | -7.852M |
| December 31, 2018 | -6.412M |
| September 30, 2018 | -4.926M |
| June 30, 2018 | -3.312M |
| March 31, 2018 | -3.847M |
| September 30, 2017 | -5.086M |
| June 30, 2017 | -6.674M |
| March 31, 2017 | -5.686M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 371.40M |
| Bruker Corp. | -50.90M |
| Danaher Corp. | 870.00M |
| Harvard Bioscience, Inc. | -2.91M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 8.171M |
| Total Expenses (Quarterly) | 15.59M |
| EPS Diluted (Quarterly) | -0.6429 |
| Enterprise Value | 13.71M |
| Gross Profit Margin (Quarterly) | 52.80% |
| Profit Margin (Quarterly) | -90.85% |
| Earnings Yield | -252.1% |
| Normalized Earnings Yield | -244.70 |